DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Bethesda North Marriott Hotel and Conference Center

2014年4月09日 (水) 午前 7:00 - 2014年4月10日 (木) 午後 5:45

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Global Labeling 2014: Compliance in a Changing Regulatory Environment

Session 7 - Hot Topics in Canada

Session Chair(s)

Mark  Collins, PHD, MBA

Mark Collins, PHD, MBA

Principal Consultant

Opus Regulatory, United States

In this session, plain language labeling will be discussed. Speakers will highlight the draft, published regulations concerning plain language labeling, an attempt to make drug labeling understandable by focusing on five targeted amendments which will provide: 1) a requirement for clear understandable, plain language labels; 2) required label mock-ups at time of review; 3) look-alike, sound-alike brand name assessments; 4) label contact information to report problems; and 5) a standard table format for key label information for nonprescription drugs. This session will also cover the final guidance, Labeling of Pharmaceutical Drugs for Human Use, highlighting changes from the 2010 draft and key points.

Speaker(s)

Bruce  Boulton, MSC

Hot Topics in Canada: Draft Plain Language Labeling Regulations

Bruce Boulton, MSC

Health Canada, Canada

Product Information Officer, Bureau Gastroenterology, Infection & Viral Diseases

Bruce  Boulton, MSC

Final Guidance – Labeling of Pharmaceutical Drugs for Human Use

Bruce Boulton, MSC

Health Canada, Canada

Product Information Officer, Bureau Gastroenterology, Infection & Viral Diseases

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。